Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month Experience

Importance: Passive antibody transfer is a longstanding treatment strategy for infectious diseases that involve the respiratory system. In this context, human convalescent plasma has been used to treat coronavirus disease 2019 (COVID-19), but the efficacy remains uncertain. Objective: To explore pot...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:medRxiv
Päätekijät: Joyner, Michael J, Senefeld, Jonathon W, Klassen, Stephen A, Mills, John R, Johnson, Patrick W, Theel, Elitza S, Wiggins, Chad C, Bruno, Katelyn A, Klompas, Allan M, Lesser, Elizabeth R, Kunze, Katie L, Sexton, Matthew A, Diaz Soto, Juan C, Baker, Sarah E, Shepherd, John R.A., van Helmond, Noud, van Buskirk, Camille M, Winters, Jeffrey L, Stubbs, James R, Rea, Robert F, Hodge, David O, Herasevich, Vitaly, Whelan, Emily R, Clayburn, Andrew J, Larson, Kathryn F, Ripoll, Juan G, Andersen, Kylie J, Buras, Matthew R, Vogt, Matthew N.P., Dennis, Joshua J, Regimbal, Riley J, Bauer, Philippe R, Blair, Janis E, Paneth, Nigel S, Fairweather, DeLisa, Wright, R. Scott, Carter, Rickey E, Casadevall, Arturo
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Cold Spring Harbor Laboratory 2020
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7430623/
https://ncbi.nlm.nih.gov/pubmed/32817978
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.08.12.20169359
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia